The IBS Implant System II is intended to replace missing teeth to restore chewing function. The IBS Implant System II can be placed in support of single or multiple-unit restorations including; cement retained, or overdenture restorations, and terminal or immediate abutment support for fixed bridgework. This system is for one or two stage surgical procedures. This system is intended for delayed loading.

Device Description

An endosseous dental implant is a device made of a material such as Ti 6AL 4V Eli (Conforming to ASTM Standard F-136). The IBS Implant System II is consists of dental fixtures, screws and multiunit abutment cylinders.

AI/ML Overview

The provided document is a 510(k) summary for the IBS Implant System II, a dental implant device. It primarily focuses on demonstrating substantial equivalence to predicate devices based on design, materials, indications for use, and non-clinical testing. It does not describe an acceptance criteria study with the requested details (number of experts, sample size for test/training set, ground truth methods, MRMC study, or standalone performance).

Instead, the document details a comparison of the new device to existing devices (predicates) regarding various technical specifications and non-clinical test results.

Since the document does not contain the information for acceptance criteria and a study proving device meets it as requested, I cannot complete the table or answer the specific questions.

No information for the requested table and study details is available in the provided text. The document focuses on demonstrating substantial equivalence through comparison with predicate devices and non-clinical tests (biocompatibility, endotoxin, sterilization validation, shelf-life validation, fatigue). These are not presented as a study with specific acceptance criteria that the device performed against in the way an AI/software performance study would be evaluated.

Therefore, the requested table of acceptance criteria and reported device performance cannot be generated. Similarly, specific details about sample size (training/test), data provenance, expert involvement, adjudication, MRMC, or standalone performance are not provided as these types of studies are typically associated with performance claims for diagnostic or prognostic devices, not for substantial equivalence of an endosseous dental implant based on physical and material properties.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 15, 2017

InnoBioSurg Co., Ltd. % April Lee Consultant Withus Group Inc 2531 Pepperdale Drive Rowland Heights, California 91748

Re: K162099

Trade/Device Name: IBS Implant System II Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: January 10, 2017 Received: January 17, 2017

Dear April Lee:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Michael J. Ryan -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K162099

Device Name IBS Implant System II

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

Submitter

InnoBioSurg Co., Ltd. Bo-reum Yoo 44-19, Techno 10-ro, Yuseong-gu, Daejeon, 34027 Republic of Korea Email: bryoo@ibsimplant.com Tel. +82-42-933-2879 Fax. +82-42-933-2881

Official Correspondent

WithUS Group Inc April Lee 2531 Pepperdale Drive Rowland Heights, CA 91748 USA Email: withus6664@gmail.com Phone: 1-909-274-9971 Fax: 1-909-460-8122

Device Information

Trade Name: IBS Implant System II
Common Name: Dental Implant System
Classification Name: Endosseous dental implant
Primary Product Code: DZE
Secondary Product Code: NHA
Panel: Dental
. Regulation Number: 872.3640
Device Class: Class II
Date prepared: 02/14/2017

General Description

The diameters and lengths of the IBS Implant System II are below:

Fixture: NR Fix

Diameter	Length
Ø3.5mm	9 mm
	11 mm
	13 mm
Ø3.8 mm	7 mm
	10 mm
	11 mm
	12 mm
	13 mm
	14 mm
	15 mm

{4}------------------------------------------------

2) Fixture: Magic FC

Diameter	Length
Ø4.0 mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm
Ø4.5 mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm
Ø5.0mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm
Ø5.5 mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm
Ø6.0 mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm
Ø6.5 mm	7 mm
	9 mm
	11 mm
	13 mm
	15 mm

The implant-abutment connection is tight and precise fitting with internal hex and Morse taper bevel. The subject device is compatible with the following abutments:

K number	Compatible Abutments
K153350	magic screw, healing abutment, angled abutment, pair abutment(non-hexa), screw retainedtype abutment, solid abutment and solid abutment cap, magic abutcoping, UCLA abutment,and Multi unit abutment

The surface of the system has been treated with SLA (sand-blasted, large-grit, acid-etched) by increasing the area of bone-implant interface.

Fixtures and cover screw are packaged together and supplied sterile. Cover Screw (HISC00) was cleared from K140806.

Cylinders are used in conjunction with screw retained type Abutment to provide support for screw type final prosthesis, and for fabrication of custom abutment for screw retained restorations.

The screw retained type is used for fabricating the single-unit prosthesis, and the multi-unit prosthesis.

{5}------------------------------------------------

3) Multiunit Ti Cylinder

Diameter	Length	Remark
Ø3.5 mm	12 mm	Hexa/Non-Hexa
Ø4.0 mm
Ø4.5 mm
Ø5.0 mm
Ø5.5 mm
Ø6.0 mm

4) Multiunit Temporary Cylinder

Diameter	Length	Remark
Ø3.5 mm	12 mm	Hexa/Non-Hexa
Ø4.0 mm
Ø4.5 mm
Ø5.0 mm
Ø5.5 mm
Ø6.0 mm

5) Multiunit Plastic Cylinder

Diameter	Length	Remark
Ø3.5 mm	12 mm	Hexa/Non-Hexa
Ø4.0 mm
Ø4.5 mm
Ø5.0 mm
Ø5.5 mm
Ø6.0 mm

6) Magic Motion

Magic Motion is an attachment-retained prosthetic product, which is used with patients with a fully edentulous maxilla. It is an one-piece structure. Various collar heights of the magic motions can be selected based on the gingival height. Magic motion does not have movement and it is a solid type.

Product name	Diameter	Cuff	Length
Magic Motion	3.9 mm	1 mm	9.65 mm
		2 mm	10.65 mm
		3 mm	11.65 mm
		4 mm	12.65 mm
		5 mm	13.65 mm
		6 mm	14.65 mm
		7 mm	15.65 mm
		8 mm	16.65 mm

Indication for Use

The IBS Implant System II is intended to replace missing teeth to restore chewing function. The IBS Implant System II can be placed in support of single or multiple-unit restorations including; cement retained, screw retained, or overdenture restorations, and terminal or immediate abutment support for fixed bridgework. This system is for one or two stage surgical procedures. This system is intended for delayed loading.

{6}------------------------------------------------

Materials:

The dental implants are fabricated from Ti 6AL 4V Eli (Conforming to ASTM Standard F-136). The abutments are fabricated from Ti 6AL 4V Eli and Poly Diacetate.

Non-Clinical Data:

The subject device was tested to evaluate its substantial equivalence according to the following standards.

Biocompatibility tests according to ISO 10993-1, ISO 10993-10 and ISO 10993-10 and ISO 10993-11 ●
. Endotoxin Test according to USP <85>

Below tests were performed for predicate devices and leveraged for the subject device:

Gamma Sterilization Validation Test according to ISO11137-1,-2 referenced in K153350
End User Steam Sterilization Test according to AAMI TIR12:2010 referenced in K140806 ●
Shelf life Validation Test according to ISO 11607-1, -2, and ASTM F1980-07 referenced in K153350
Fatigue Test according to ISO 14801 referenced in K153350 ●

Non-clinical tests followed the recommendations in the "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implant and Endosseous Dental Implant abutments". Surface treatment analysis were performed to support the decision of substantial equivalence.

Comparison to Predicate Devices:

1. Fixtures
K153350, IBS Implant System by InnoBioSurg Co., Ltd. ●
K140440, Noris Medical Dental Implants System by Noris Medical Ltd. .

	Subject device	Primary Predicate device	Reference Device
ProductName	IBS Implant SystemII	IBS Implant System	Noris Medical DentalImplants System
510(k)Product codeClass	N/ADZEII	K153350DZEII	K140440DZEII
Manufacturer	InnoBioSurg Co., Ltd.	InnoBioSurg Co., Ltd.	Noris Medical Ltd.
Indication foruse	Identical to thePredicate devices	Intended for use in partially orfully edentulous mandibles andmaxillae, in support of single ormultiple-unit restorationsincluding; cement-retained,	Noris Medical DentalImplants System is intendedto replace missingtooth/teeth in either jaw forsupporting prosthetic
		screw- retained, or overdenturerestorations, and terminal orintermediate abutment supportfor fixed bridgework. Thissystem is dedicated for one andtwo stage surgical proceduresand not dedicated forimmediate loading. This systemis intended for delayed loading.	devices that may aid inrestoring the patientschewing function. Theprocedure can beaccomplished in a one-stageor two-stage surgicaloperation. All implants areappropriate for immediateloading when good primarystability is achieved andwith appropriate occlusalloading.
Design		Image: Implant	Image: Implant
Compositionof Material	Titanium AlloyTi-6Al-4V EliASTM F136	Titanium AlloyTi-6Al-4V EliASTM F136	Titanium AlloyTi-6Al-4V EliASTM F136
Prostheticconnection	Identical	Internal Hex	Internal Hex
EndosseousImplant	Identical	Tapered, macrothreads	Tapered, micro · macrothreads
Components	Identical	Various abutments andaccessories	Various abutments andaccessories
Range ofDiameters(mm)	Identical	NR Fix : 3.5, 3.8mmMagic Fc : 4.0, 4.5, 5.0, 5.5,6.0, 6.5 mm	3.3, 3.75, 4.2, 5, 6mm
Range ofLengths(mm)	Identical	NR Fix : 9, 10, 11, 12, 13,14mmMagic FC : 7, 9, 11, 13, 15mm	8, 10, 11.5, 13, 16mm
ModifiedSurface	S.L.A	R.B.M.	S.L.A
SurgicalTechnique	Identical	1 stage and 2 stage, self tapping	1 stage and 2 stage, selftapping
GammaSterilization	Identical	Yes	Yes

{7}------------------------------------------------

{8}------------------------------------------------

2) Abutment

K153350, IBS Implant System by InnoBioSurg Co., Ltd. .
. K142813, Biogenesis Implant System-Kisses by Biogenesis Co., Ltd.

	Subject Device	Primary Predicate	ReferencePredicate	ReferencePredicate
Manufacturer	Innobiosurg Co., Ltd	Innobiosurg Co., Ltd	Biogenesis Co.,Ltd	Innobiosurg Co.,Ltd
Device Name	IBS Implant SystemII	IBS Implant System	Biogensis ImplantSystem-Kisses	IBS ImplantSystem
510(k) No.	N/A	K153350	K142813	K140806
Design	Image: Cylinders	Image: Burn out (Plastic)Cylinder	Image: The Biogenesis Implant System	-
	Image: Magic Motion	-	-
Indicationfor use	Identical to thePredicate devices	IBS Implant systemis intended for usewith a dentalimplant to providesupport forprostheticrestorations such ascrowns, bridges, oroverdentures.	The BiogenesisImplant System –Kisses is indicatedfor use in partiallyor fully edentulousmandibles andmaxillae, insupport of singleor multiple-unitrestorationsincluding; cementretained, screwretained, oroverdenturerestorations andterminal orintermediateabutment supportfor fixedbridgework. TheBiogenesisImplant System –Kisses is for singleand two stagesurgicalprocedures. It is	IBS Implant systemis intended for usewith a dentalimplant to providesupport forprostheticrestorations such ascrowns, bridges, oroverdentures.
			for delayedloading.
ConnectionType	Internal Hex-Connected	Internal Hex-Connected		Internal Hex-Connected
Diameters	Cylinders : 3.5, 4.0,4.5, 5.0, 5.5, 6.0 mmMagic Motion : 3.9mm	4.5, 5.5, 6.5mm	3.0mm, 3.5mm	4.0, 4.5, 5.0, 5.5,6.0, 6.5mm
Lengths	Cylinders : 12mm	14.8mm		10.6, 11.6, 12.6,13.6, 14.6, 15.6mm
G/H Length(mm)	MagicMotion :1mm-8mm	1mm-4mm	0.5mm-7mm	1mm-4mm
Angle(°)	No Angulation	No Angulation	No Angulation	No Angulation
Material	Titanium AlloyPoly Diacetate	Titanium AlloyPoly Diacetate	Titanium Alloy	Titanium Alloy
Surface	Machine	Machine	Anodizingcoloring - Goldcolor (EntireBody)	Machine
Sterilization	Non-Sterile	Non-Sterile	Non-Sterile	Non-Sterile

{9}------------------------------------------------

Substantial Equivalence Discussion

Similarities

The indications for use, material, general shape design, dimension, surface, connection to abutment method, application method and sterilization method between the IBS Implant System II and the predicate devices are similar.

Differences

1) Fixtures

The difference between the subject device and the primary predicate device is the surface treatment method of the fixture. The surface of the fixture of the primary predicate has been treated with RBM (Resorbable Blasted media) and the surface of the subject device has been treated with SLA (sand-blasted, large-grit, acid-etched). The reference predicate device, Noris Medical Dental Implants System (K140440) has the same surface treatment as the subject device.

2) Cylinders

Another difference is the dimension and design of the multiunit abutment cylinder. The range of the diameters of the subject device is 3.5 to 6.0mm and the length of the subject device is 12mm. The range of the diameters of the primary predicate device is 4.5 to 6.5mm and the length of the primary predicate device is 14.8mm. While the outer surface of the predicate device is smooth, the outer surface of the subject device is designed with grooves, which allow resin to stick well and thus make it easier to manufacture the frame of the teeth.

{10}------------------------------------------------

3) Magic Motions

The difference is the diameter size of the magic motion. The diameter of the subject device is 3.9mm and is a bit bigger than the predicate's which are 3.0 mm and 3.5mm.

Brief Discussion

The differences between the subject device and predicate device are the fixture's surface treatment, cylinders' design and dimension, and magic motions' diameter size. For the fixture's surface treatment, as we provided the SLA analysis information and the predicate, K140440 has the same surface treatment. According to the indication for use of the cylinder with appropriate diameter and length is used for hand-milling. Since the selection of an appropriate cylinder may reduce the milling time and deletion. the smaller diameter or the shorter length in comparison with the predicate device does not affect the substantial equivalence. An appropriate size of cylinder locked on the abutment may be used. Accordingly we can claim the substantially equivalence of the subject device to predicate device. For the magic motion's size, as the subject device's diameter is bigger than the predicate's. Any differences between the IBS Implant System II and predicate device do not raise questions. Accordingly we can claim the substantially equivalence of the IBS Implant System II to predicate device.

Conclusion

The IBS Implant System II. subject device of this submission, constitutes a substantially equivalent medical device, meeting all the declared requirements of its intended use. This system has the same intended use and fundamental scientific technology as its predicate devices. Therefore, IBS Implant System II and its predicates are substantially equivalent.

Regulation Number and Section

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.